Document is current
Any future updates will be listed below
-
Authors
Zhang, Miao
Zhou, Xiaolei
Li, Zhenzhen
Zhao, TianYu
Miao, Yu
Liu, Sen
Han, Qiaoqiao
Wang, Libo
Xu, Yongdeng
Cui, Tao
Wang, Ze
Yi, Xiulin
Yan, Fengying
Wang, Xiaoliang
-
Funding
Funding for this research was provided by:
Project of Science and Technology Program of Tianjin (23ZGCXQY00050, 24ZXZSSS00480)
Project of State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine (712023001)
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 16 June 2025
First Online: 7 July 2025
Declarations
:
: All the animal procedures were approved by IACUC committee at TIPR, according to Guide for the Care and Use of Laboratory Animals (National Research Council of the USA, 1996) and related ethical regulations of the China Academy of Chinese Medical Sciences. The protocols were approved by the Animal Ethics Committee of Laboratory Animals at the Institute of Laboratory Animal Resources of Tianjin (Tianjin, China) (2023110301). The maximal tumor size allowed by the Ethics Committee is 2cm3 and the maximal tumor size was not exceeded. We confirm that the study is reported in accordance with ARRIVE guidelines. After the completion of the experiment, the mice were sacrificed by cervical dislocation under anesthesia. The study was approved by the Medical Ethics Committee of the First Central Hospital of Tianjin under grant number 2020N221KY.
: Not applicable.
: The authors declare no competing interests.
